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ABSTRACT
Among 36 cases of Escherichia coli native valve endocarditis (NVE) that met Duke criteria (31 cases in the
literature between 1909 and 2002, and ﬁve cases seen in Paris, France), the urinary tract was the most
common portal of entry. The majority (72.2%) of cases developed in elderly females. Overall, the
proportion of patients aged > 70 years rose from 5.3% in 1982 to 22.9% in 2002. Persistent E. coli
bacteraemia in the elderly in the absence of cardiac risk-factors may be a sign of NVE and should
prompt an investigation by echocardiography.
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Despite being a common cause of bacteraemia,
Escherichia coli has been implicated rarely in the
occurrence of native valve endocarditis (NVE) [1].
Only 20 well-documented cases of Duke criteria-
deﬁnite E. coli NVE appeared in the literature
between 1945 and 1992 [1–4], with only rare cases
reported subsequently [5–8]. Thus, in a studyof 132
cases of positive blood cultures caused by Entero-
bacteriaceae, NVE was responsible for seven
(5.3%) cases [9], but none of these was caused by
E. coli. In addition, in clinical series of infective
endocarditis (IE) in the elderly, it seems that
Enterobacteriaceae, and E. coli in particular, play
only aminor role [10].However, as shown in Fig. 1,
the number of reports of elderly patients with
E. coli NVE has recently increased. Therefore, a
further increase in the number of cases of E. coli
NVE might be expected in the future, since the
demographic characteristics of at-risk patients are
changing, with more elderly patients having
degenerative valvular lesions [11].
The higher frequency of E. coli NVE in elderly
patients can be explained by the altered vaginal
mucosa in women and the higher rate of
diabetes mellitus, both of which increase the
risk of developing urinary tract infection.
Immunosuppressive therapy and progressive
cancer can further enhance the risk for bacter-
aemia in patients with urinary tract infection,
with E. coli being the most common cause of
Gram-negative bacteraemia. Indeed, among con-
ﬁrmed cases of E. coli NVE, the male:female
ratio was 10:26, i.e., 72.2% females, even though
IE is more frequent among elderly men [12].
Meyers et al. [13] reviewed the clinical course
and outcome of 100 episodes of bacteraemia
among patients aged > 65 years, and found that
the urinary tract was the most common portal
of entry (27%), rising to 75% (6 ⁄ 8) for NVE in
patients aged > 70 years. Gram-negative bacter-
aemia was much more common in patients aged
‡ 70 years, and the mortality rate for these
patients was higher than that for younger
patients [14]. Among 191 patients aged
> 60 years who developed bacteraemia,
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community-acquired infections accounted for
57.5% of cases, predominantly E. coli (26.1%)
and Klebsiella spp. (25.4%) [15].
We recently followed ﬁve patients in our
university hospital with E. coli NVE and com-
pared their characteristics with those of cases
identiﬁed with sufﬁcient information from an
exhaustive literature review (31 cases of Duke
criteria-deﬁnite E. coli NVE between 1909 and
December 2002). All 36 cases had Duke criteria-
deﬁnite IE. The median age was signiﬁcantly
higher for the ﬁve recent cases than for those
reported previously (81 years (range 71–86 years)
vs. 47 years (range 12–79 years); p 0.0009). Con-
sidering all the cases, the mitral valve (20 ⁄ 36;
55.6%) was involved most frequently. Four (80%)
of the ﬁve recent patients with no cardiac risk-
factor had NVE with urinary tract infection,
compared with nine (31%) patients reported
previously (p < 0.05).
Russo and Johnson [16] have proposed the
acronym ‘ExPEC’ (extra-intestinal pathogenic
E. coli) as a new inclusive designation for certain
strains of E. coli that cause extra-intestinal infec-
tions associated with particular virulence factors
[16]. ExPEC strains are now known to belong
predominantly to E. coli phylogenetic group B2
and, to a lesser extent, group D, unlike commen-
sal strains, which belong to phylogenetic groups
A and B1 [17]. Furthermore, ExPEC strains har-
bour multiple virulence factors that enable them
to adhere, invade, escape host defences or acquire
essential nutrients, such as iron [18,19]. The ﬁve
recent E. coli endocarditis isolates from our hos-
pital also belonged to the most prevalent phylo-
genetic groups, B2 (n = 4) or D (n = 1), found
among ExPEC strains, and each of the ﬁve isolates
had a different virulence genotype (Table 1).
Thus, these recent IE strains exhibited typical
ExPEC traits and resembled strains responsible
for urosepsis, since four of them expressed
PapG II adhesion [18]. However, as these ﬁve
isolates had different virulence genotypes, the
emergence of a single virulent clone seemed
unlikely. Although Gould et al. [20] showed that
some E. coli strains were unable to adhere to
isolated human or canine aortic valve leaﬂets, it
remains to be determined whether these isolates
had any particular propensity to adhere to and
destroy endocardium. The fact that none of the
ﬁve patients had been diagnosed previously with
cardiac disease suggests that E. coli may attack
and damage a healthy valve. However, until now,
no genetic determinant involved in the patho-
physiology of endocarditis has been described in
E. coli strains. The possible emergence of new
highly virulent E. coli strains could have a major
impact on public health because of the ever-
increasing life-expectancy and multiple co-mor-
bidities common among the elderly.
In conclusion, E. coli NVE is a rare cause of
acute sepsis in elderly patients with pyelonephri-
tis. Underlying conditions often include immune
deﬁciencies. Persistent E. coli bacteraemia in an
elderly patient should now suggest the possibility
of NVE and prompt an investigation by echocar-
diography. E. coli NVE is mainly caused by
strains with the typical traits of E. coli strains
causing urosepsis. This emerging syndrome
underscores the need to set up a prospective
network to study extra-intestinal E. coli sepsis in
elderly patients.
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Fig. 1. Reported cases of Escherichia coli native valve
endocarditis (NVE) and those occurring in patients aged
> 70 years. Age was available for 35 ⁄ 36 cases.
Table 1. Phylogenetic groups and virulence genotypes of
ﬁve recent Escherichia coli isolates associated with cases of
native valve endocarditis
Isolate
Phylogenetic
group K1 papG sfaS ibeA iucC hly cnf1 fyuA iroN
1 B2 – IIa – – – + + + +
2 B2 – – + + + – – + +
3 D – II – – + – – + –
4 B2 – II – – + + – + +
5 B2 – II – – + – – + +
+, presence of trait; –, absence of trait; K1, capsular antigen; papG, P ﬁmbrial
adhesin; sfaS, S ﬁmbrial adhesin; ibeA, invasin of brain endothelium A; iucC,
aerobactin siderophore; hly, haemolysin; cnf1, cytotoxic necrotising factor 1; fyuA,
yersiniabactin siderophore; iroN, salmochelin siderophore.
aVariant allele of papG.
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